Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Venkatrao, M., Nagarathna, R., Majumdar, V., Patil, S. S., Rathi, S., & Nagendra, H. (2020). Prevalence of obesity in India and its neurological implications: A multifactor analysis of a nationwide cross-sectional study. Annals of Neurosciences., 27(3–4), 153–161. https://doi.org/10.1177/0972753120987465
2. De Lorenzo, A., Romano, L., Di Renzo, L., Di Lorenzo, N., Cenname, G., & Gualtieri, P. (2019). Obesity: a preventable, treatable, but relapsing disease. Nutrition, 17, 110615. https://doi.org/10.1016/j.nut.2019.110615
3. Sudhakar, M., Winfred, S. B., Meiyazhagan, G., & Venkatachalam, D. P. (2022). Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Molecular and cellular biochemistry, 477(4), 1155–1193.
4. Jakab, J., Miškić, B., Mikšić, Š., Juranić, B., Ćosić, V., Schwarz, D., & Včev, A. (2021). Adipogenesis as a potential anti-obesity target: A review of pharmacological treatment and natural products. Diabetes, Metabolic Syndrome and Obesity, 14, 67–83. https://doi.org/10.2147/DMSO.S281186
5. Makris, M. C., Alexandrou, A., Papatsoutsos, E. G., Malietzis, G., Tsilimigras, D. I., Guerron, A. D., & Moris, D. (2017). Ghrelin and obesity: Identifying gaps and dispelling myths. A reappraisal. In Vivo, 31(6), 1047–1050.